COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports. Dermatology Reports, [S. l.], v. 16, n. 2, 2023. DOI: 10.4081/dr.2023.9763. Disponível em: https://journals.pagepress.org/dr/article/view/9763. Acesso em: 19 jun. 2025.